Gastric Cancer News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Question Over Ramucirumab in First-Line Gastric Cancer - Medscape - Medscape



Medscape
 
Question Over Ramucirumab in First-Line Gastric Cancer - Medscape 
Medscape
SAN FRANCISCO ? Adding the antiangiogenesis agent ramucirumab (Cyramza, Eli Lilly) to first-line chemotherapy conferred a significant reduction in the risk for disease progression or death among patients with metastatic gastric or gastroesophageal ...
Adding Ramucirumab to Frontline Chemo Does Not Improve ... OncLive
First-Line Ramucirumab Delays Progression in Gastric ... Cancer Network
Small PFS Bump in Gastric/GEJ Cancer MedPage Today

all 4 news articles » 


Extensive Intraoperative Peritoneal Lavage May Not Improve OS in Gastric Cancer - Cancer Therapy Advisor



Cancer Therapy Advisor
 
Extensive Intraoperative Peritoneal Lavage May Not Improve OS in Gastric Cancer 
Cancer Therapy Advisor
Previous research suggested that EIPL may improve survival by reducing the number of intraperitoneal-free cancer cells. The following article features coverage from the 2018 Gastrointestinal Cancers Symposium. Click here to read more of Cancer Therapy ...

 


MSI Testing's Impact on Immunotherapy in Gastric Cancers - OncLive - OncLive



MSI Testing's Impact on Immunotherapy in Gastric Cancers - OncLive 
OncLive
Yelena Y. Janjigian, MD, identifies the role of MSI testing in tangent with immunotherapy for the treatment of advanced gastric and GEJ cancers.

and more » 


HIPEC Increased Survival in Gastric Cancer With Peritoneal Metastasis - Cancer Network



HIPEC Increased Survival in Gastric Cancer With Peritoneal Metastasis 
Cancer Network
?In selected patient with localized or limited peritoneal carcinoma disease from gastric cancer, HIPEC combined with complete cytoreductive surgery increased both overall survival and disease-free survival without increasing postoperative outcomes ...

 


Trastuzumab Deruxtecan Active in HER2-Expressing Gastric Cancer - OncLive



OncLive
 
Trastuzumab Deruxtecan Active in HER2-Expressing Gastric Cancer 
OncLive
?Gastric cancer can be difficult to treat due to its molecular complexity, and currently there are no HER2-targeted therapies or antibody-drug conjugates approved for HER2-positive advanced gastric cancer that progresses following treatment with ...

and more » 


'I Loved The Daylights Out Of Her': Paul And Ev's Heart-Wrenching Love Story - CBS Minnesota / WCCO



CBS Minnesota / WCCO
 
'I Loved The Daylights Out Of Her': Paul And Ev's Heart-Wrenching Love Story 
CBS Minnesota / WCCO
MINNEAPOLIS (WCCO) ? A Chisago County woman spent the final months of her life encouraging others to live life to the fullest. Ev Jacobson was 53 years old when she lost her battle with cancer last week. Ev was married to Twin Cities radio host Paul ...

 


Ask The Expert: Stomach cancer can come in many forms - Baltimore Sun



Baltimore Sun
 
Ask The Expert: Stomach cancer can come in many forms 
Baltimore Sun
There are several different types of stomach cancer, including adenocarcinoma, which arises from an abnormal gastric cell, and gastric lymphoma, which originates in the stomach. Some cancers are also show up as muscular tumors in the GI tract and ...

 


Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery Prolongs OS in Gastric Cancer - Cancer Therapy Advisor



Cancer Therapy Advisor
 
Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery Prolongs OS in Gastric Cancer 
Cancer Therapy Advisor
Compared with cytoreductive surgery alone (CRSa), hyperthermic intraperitoneal chemotherapy (HIPEC) plus CRS prolongs overall survival (OS) among patients with gastric cancer and peritoneal carcinomatosis (PC), according to an abstract being presented ...

 


Dr. Catenacci on Results of Margetuximab Plus Pembrolizumab in Gastric/GEJ Cancer - OncLive



OncLive
 
Dr. Catenacci on Results of Margetuximab Plus Pembrolizumab in Gastric/GEJ Cancer 
OncLive
Daniel Catenacci, MD, medical oncologist, assistant professor of medicine, Univeristy of Chicago Medicine, discusses margetuximab (MGAH22-10) plus pembrolizumab (Keytruda) as treatment for patients with advanced HER2-positive gastroesophageal junction ...

 


Biomarkers may help predict outcomes in gastric cancer patients who abuse alcohol - Science Daily



Biomarkers may help predict outcomes in gastric cancer patients who abuse alcohol 
Science Daily
"Alcohol consumption is a known risk factor for gastric cancer, which carries high morbidity and mortality in China. We found that DNA repair-related markers -- BRF1, BRCA1/2, and MPO -- have good prognostic value in gastric cancer patients with or ...

and more »